Patient Guide: A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 45 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05415215
Status: COMPLETED
Condition: Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 45 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Buenos Aires,
  • Ciudad Autonoma Buenos Aires,
  • Banja Luka,
  • • And 42 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily